153 related articles for article (PubMed ID: 11883111)
1. [Mucolipidosis II with unusual biochemical parameters].
Morava E; Eduard P; Tóth G; Dobos M; Melegh B; Kosztolányi G
Orv Hetil; 2002 Jan; 143(3):135-7. PubMed ID: 11883111
[TBL] [Abstract][Full Text] [Related]
2. Self-mutilation in a patient with mucolipidosis III.
Zammarchi E; Savelli A; Donati MA; Pasquini E
Pediatr Neurol; 1994 Jul; 11(1):68-70. PubMed ID: 7986298
[TBL] [Abstract][Full Text] [Related]
3. [Total activity and distribution of multiple forms of lysosomal glycosidases in subfractions of human leukocytes].
Kuz'micheva NA; Vidershaĭn GIa
Vopr Med Khim; 1984; 30(5):76-81. PubMed ID: 6241372
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of I-cell disease.
Hwu WL; Chuang SC; Wang WC; Wang TR
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(6):508-13. PubMed ID: 7831983
[TBL] [Abstract][Full Text] [Related]
5. I-cell disease: evidence for a mannose 6-phosphate independent pathway for translocation of lysosomal enzymes in lymphoblastoid cells.
Tsuji A; Omura K; Suzuki Y
Clin Chim Acta; 1988 Aug; 176(1):115-21. PubMed ID: 2971480
[No Abstract] [Full Text] [Related]
6. Mucolipidoses II and III variants with normal N-acetylglucosamine 1-phosphotransferase activity toward alpha-methylmannoside are due to nonallelic mutations.
Ben-Yoseph Y; Mitchell DA; Yager RM; Wei JT; Chen TH; Shih LY
Am J Hum Genet; 1992 Jan; 50(1):137-44. PubMed ID: 1309624
[TBL] [Abstract][Full Text] [Related]
7. Clinical variability in mucolipidosis III (pseudo-Hurler polydystrophy).
Tylki-Szymańska A; Czartoryska B; Groener JE; Ługowska A
Am J Med Genet; 2002 Mar; 108(3):214-8. PubMed ID: 11891688
[TBL] [Abstract][Full Text] [Related]
8. Highly increased levels of serum beta-hexosaminidase, arylsulphatase A and beta-galactosidase in a patient with sepsis.
Tønnesen T; Andersen P; Güttler F
J Inherit Metab Dis; 1988; 11(4):428-9. PubMed ID: 2907595
[No Abstract] [Full Text] [Related]
9. Effect of bacterial endotoxin on lysosomal enzyme activities of normal and mucolipidosis III fibroblasts.
Di Natale P; Stabile M; Ronsisvalle L; Utili R
Biomedicine; 1981 May; 35(2):46-9. PubMed ID: 7260237
[TBL] [Abstract][Full Text] [Related]
10. [Mucolipidosis: clinical and genetic aspects].
Kolodny EH
Rev Neurol; 1998 Aug; 27(156):337-41. PubMed ID: 9736966
[TBL] [Abstract][Full Text] [Related]
11. Neuraminidase deficiency presenting as non-immune hydrops fetalis.
Beck M; Bender SW; Reiter HL; Otto W; Bässler R; Dancygier H; Gehler J
Eur J Pediatr; 1984 Dec; 143(2):135-9. PubMed ID: 6240403
[TBL] [Abstract][Full Text] [Related]
12. GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha/beta: a case report.
Ho CC; Tsung LL; Liu KT; Poon WT
BMC Med Genet; 2018 Sep; 19(1):162. PubMed ID: 30208878
[TBL] [Abstract][Full Text] [Related]
13. [Intracellular activity and secretion of various lysosomal glycosidases in cultured human skin fibroblasts].
Ivleva TS; Beliaeva ID; Vidershaĭn GIa
Biokhimiia; 1986 Jul; 51(7):1150-5. PubMed ID: 2942192
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and ultrastructural diagnostic problems in mucolipidoses.
László A; Lászik Z; Klujber L; Havass Z
Acta Paediatr Hung; 1991; 31(4):423-32. PubMed ID: 1790025
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis of mucolipidosis type II on first-trimester amniotic fluid.
Poenaru L; Mezard C; Akli S; Oury JF; Dumez Y; Boue J
Prenat Diagn; 1990 Apr; 10(4):231-5. PubMed ID: 1973293
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity of I-cell disease is demonstrated by complementation of lysosomal enzyme processing mutants.
Shows TB; Mueller OT; Honey NK; Wright CE; Miller AL
Am J Med Genet; 1982 Jul; 12(3):343-53. PubMed ID: 6287841
[TBL] [Abstract][Full Text] [Related]
17. The mucolipidoses: identification by abnormal electrophoretic patterns of lysosomal hydrolases.
Honey NK; Miller AL; Shows TB
Am J Med Genet; 1981; 9(3):239-53. PubMed ID: 7282783
[TBL] [Abstract][Full Text] [Related]
18. The subcellular localization of soluble and membrane-bound lysosomal enzymes in I-cell fibroblasts: a comparative immunocytochemical study.
van Dongen JM; Willemsen R; Ginns EI; Sips HJ; Tager JM; Barranger JA; Reuser AJ
Eur J Cell Biol; 1985 Nov; 39(1):179-89. PubMed ID: 2935398
[TBL] [Abstract][Full Text] [Related]
19. The effect of (+) --cyanidanol on lysosomal enzymes of I-cell fibroblasts.
Tavella D; Donnelly PV; Di Ferrante N
Tex Rep Biol Med; 1976; 34(2-4):307-14. PubMed ID: 20673
[TBL] [Abstract][Full Text] [Related]
20. [Mucolipidoses type II. Case report].
Aracena M; Mabe P; Mena M; Andreani S; Daza C
Rev Med Chil; 2003 Mar; 131(3):314-9. PubMed ID: 12790082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
